SC 13G Filing

Company

Cardiff Oncology, Inc.

Filed

November 15, 2016

Accession Number

0000895345-16-000596

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →